determin
factor
predict
inhospit
mortal
among
patient
requir
hospit
treatment
communityacquir
pneumonia
cap
studi
design
prospect
observ
studi
patient
admit
six
hospit
edmonton
al
canada
diagnosi
cap
novemb
novemb
pneumonia
defin
two
respiratori
symptom
sign
opac
chest
radiograph
interpret
attend
physician
result
total
patient
enrol
studi
die
multivari
analysi
increas
pneumonia
sever
score
increas
age
site
care
consult
respirologist
infecti
diseas
physician
function
statu
time
admiss
independ
predict
mortal
increas
pneumonia
sever
risk
score
increas
age
site
hospit
function
statu
consult
infecti
diseas
physician
respirologist
independ
associ
earli
day
late
day
mortal
contrast
partial
complet
use
pneumonia
pathway
associ
decreas
earli
mortal
effect
late
mortal
low
lymphocyt
count
high
serum
potassium
level
associ
earli
late
mortal
type
antibiot
therapi
effect
late
earli
mortal
conclus
function
statu
time
hospit
admiss
power
predictor
mortal
incorpor
score
model
use
predict
mortal
common
predictor
earli
late
inhospit
mortal
earli
mortal
affect
time
type
antibiot
therapi
wherea
late
mortal
influenc
type
antibiot
therapi
hyperkalemia
lymphopenia
associ
earli
mortal
abbrevi
cap
communityacquir
pneumonia
ci
confid
interv
fsa
forward
sortat
area
hrct
highresolut
ct
odd
ratio
c
ommunityacquir
pneumonia
cap
common
ill
incid
rate
approxim
adult
per
year
approx
imat
requir
admiss
hospit
mean
age
patient
hospit
treatment
cap
period
alberta
year
sd
median
age
year
inhospit
mortal
rate
patient
cap
consider
vari
popul
studi
howev
administr
databas
studi
larg
popul
avail
mortal
rate
rang
past
year
attent
paid
process
care
impact
outcom
pneumonia
critic
pathway
diseasespecif
manag
strategi
defin
essenti
step
complex
care
process
pathway
introduc
tri
reduc
variat
care
introduc
pneumonia
pathway
six
hospit
provid
care
adult
greater
edmonton
area
object
studi
determin
factor
influenc
inhospit
mortal
patient
cap
whether
adher
pathway
effect
mortal
studi
involv
six
hospit
edmonton
area
adult
popul
two
tertiari
care
hospit
two
hospit
provid
secondari
tertiari
care
two
commun
hospit
studi
approv
research
ethic
committe
univers
alberta
multidisciplinari
team
develop
comprehens
pathway
manag
cap
pathway
consist
admiss
guidelin
preprint
order
cover
routin
aspect
care
algorithm
administr
discontinu
supplement
oxygen
antimicrobi
therapi
levofloxacin
oral
cefuroxim
plu
azithromycin
iv
option
provid
option
prohibit
remind
medic
staff
regard
assess
vaccin
statu
pneumococc
influenza
vaccin
provid
recommend
administr
vaccin
indic
includ
order
sheet
addit
counsel
literatur
regard
cessat
smoke
made
avail
tobacco
smoker
threepart
discharg
algorithm
part
pathway
patient
achiev
physiolog
stabil
defin
oral
temperatur
c
h
respiratori
rate
breathsmin
h
oxygen
satur
breath
room
air
return
baselin
satur
level
abil
eat
drink
enough
maintain
hydrat
function
getupandgo
test
assess
activ
daili
live
patient
fail
getupandgo
test
miniment
statu
assess
carri
getupandgo
test
patient
ask
aris
sit
posit
walk
done
patient
pass
test
score
miniment
statu
examin
consid
pass
grade
test
result
satisfactori
comorbid
ill
stabl
patient
deem
readi
discharg
gener
function
statu
mental
statu
assess
perform
patient
year
age
function
statu
premorbid
admiss
categor
walk
walk
assist
walk
prosthesi
wheel
chair
bedbound
statu
also
record
two
symptom
sign
cap
cough
product
nonproduct
pleurit
chest
pain
short
breath
temperatur
crackl
bronchial
breath
auscult
plu
radiograph
evid
pneumonia
interpret
emerg
depart
physician
intern
medicin
consult
patient
exclud
pathway
requir
admiss
intens
care
emerg
depart
believ
aspir
pneumon
defin
pulmonari
opac
presenc
recent
loss
conscious
vomit
observ
respiratori
distress
within
min
feed
tuberculosi
cystic
fibrosi
pregnant
nurs
mother
immunosuppress
patient
mgd
prednison
month
immunosuppress
drug
also
exclud
hiv
infect
exclud
cd
count
second
year
studi
patient
aspir
pneumonia
includ
adher
pathway
classifi
complet
partial
element
pathway
follow
adher
complet
adher
incomplet
one
element
follow
canadian
censu
data
use
provid
median
household
incom
neighborhood
area
forward
sortat
area
fsa
correspond
first
three
digit
postal
code
hospit
record
two
hundr
fortyeight
uniqu
fsa
identifi
data
within
provinc
alberta
categori
median
household
incom
use
marker
socioeconom
statu
se
patient
sinc
patient
multipl
hospit
analys
limit
first
hospit
within
period
due
small
number
event
patient
prosthesi
function
statu
n
antibiot
administ
n
also
exclud
analys
site
identif
hospit
mask
af
protect
ident
particip
institut
analys
perform
softwar
sa
version
sa
institut
cari
nc
complet
case
analys
use
throughout
independ
variabl
high
percentag
miss
valu
evalu
analysi
descript
statist
mean
proport
present
differ
test
use
ftest
test
univari
analysi
use
exclud
predictor
lack
margin
relationship
allcaus
mortal
predictor
p
valu
univari
logist
regress
analysi
retain
multivari
logist
regress
model
risk
death
evalu
use
multivari
logist
regress
factor
evalu
simultan
adjust
factor
model
predictor
select
final
model
base
numer
clinic
signific
odd
ratio
or
nomin
confid
interv
ci
present
cstatist
hosmer
lemeshow
lack
fit
test
use
evalu
adequaci
logist
regress
model
hierarch
logist
regress
model
predictor
ad
one
time
also
examin
evalu
possibl
collinear
among
predictor
signific
collinear
among
factor
observ
sinc
comorbid
medic
histori
patient
account
calcul
pneumonia
sever
index
adjust
made
cox
proport
hazard
model
account
time
admiss
mortal
also
develop
result
proport
hazard
model
similar
one
multivari
logist
regress
model
present
twosid
p
valu
consid
signific
analys
sinc
adher
pneumonia
pathway
vari
among
site
care
may
result
imbal
covari
use
logist
regress
model
estim
propens
cap
pathway
use
hospit
propens
score
method
chosen
follow
cap
pathway
random
intervent
mani
factor
well
interact
affect
use
pathway
factor
select
calcul
propens
score
includ
site
age
nurs
home
resid
resid
home
care
gender
substanc
abus
studi
year
season
time
present
median
household
incom
variabl
interact
five
way
evalu
associ
cap
pathway
use
site
resid
home
care
interact
select
calcul
estim
propens
score
pathway
use
estim
propens
score
cap
pathway
incorpor
analysi
mortal
covari
model
addit
estim
propens
score
use
cap
pathway
interact
site
cap
pathway
also
evalu
multivari
logist
regress
model
mortal
result
model
estim
propens
score
shown
model
site
pathway
interact
shown
model
main
effect
similar
henc
chose
present
result
main
effect
year
studi
novemb
novemb
patient
pneumonia
met
criteria
pathway
admit
six
edmonton
hospit
tabl
addit
follow
patient
diagnosi
pneumonia
exclud
studi
patient
requir
admiss
icu
emerg
depart
patient
aspir
pneumonia
first
year
studi
onlythes
patient
includ
second
year
pneumonia
pathway
team
decid
antibiot
therapi
subset
patient
physician
choic
n
palli
care
n
pregnanc
n
immunosuppress
n
cystic
fibrosi
n
wbc
count
n
tuberculosi
n
nosocomi
pneumonia
n
bronchiectasi
n
pulmonari
fibrosi
n
bronchiol
obliteran
organ
pneumonia
n
talc
lung
n
collagen
vascular
diseas
n
sepsi
pneumonia
n
exacerb
copd
n
diagnosi
chang
pneumonia
anoth
diagnosi
attend
physician
h
admiss
n
hiv
infect
count
n
unknown
reason
n
admiss
rate
icu
emerg
depart
vari
commun
hospit
icu
patient
requir
icu
transfer
one
hospit
rate
admiss
tertiari
care
hospit
respect
secondari
care
hospit
two
commun
hospit
rate
admiss
respect
admiss
icu
ward
uncommon
occur
patient
die
mean
age
includ
patient
year
male
patient
femal
patient
patient
die
sitespecif
mortal
rate
rang
tabl
also
show
site
differ
mean
age
mean
pneumonia
sever
ill
score
mean
time
present
first
dose
antibiot
mean
length
stay
median
household
incom
thirtyon
percent
admit
nurs
home
resid
requir
care
fulli
ambulatori
requir
wheelchair
bed
bound
three
hundr
seventysix
patient
limit
care
order
one
hundr
sixtysix
patient
taken
pathway
increas
sever
pneumonia
transfer
icu
sinc
patient
elig
studi
time
hospit
admiss
includ
analysi
one
thousand
fiftyon
patient
getupandgo
test
done
patient
fail
six
hundr
seventysix
patient
miniment
statu
examin
done
patient
fail
tabl
compar
select
featur
surviv
pneumonia
vs
die
number
instruct
observ
unexpectedli
major
differ
mean
age
mean
pneumonia
sever
risk
score
mean
length
stay
two
group
also
effect
function
statu
time
admiss
subsequ
mortal
strike
thu
walk
walk
assist
wheelchair
bedridden
respect
die
mean
age
patient
group
year
respect
mean
pneumonia
sever
risk
score
patient
four
function
statu
categori
respect
ten
patient
pass
getupandgo
test
die
compar
patient
fail
test
group
pass
test
younger
year
vs
year
lower
mean
risk
score
vs
lower
percentag
patient
risk
class
iv
v
vs
major
differ
mortal
accord
site
hospit
mortal
rate
rang
shown
multivari
analysi
site
care
remain
signific
predictor
mortal
simultan
adjust
factor
type
antibiot
therapi
seem
influenc
mortal
rate
mortal
rate
patient
treat
levofloxacin
patient
treat
cefuroxim
plu
azithromycin
die
mortal
rate
among
patient
receiv
antibiot
antibiot
combin
noteworthi
time
present
emerg
depart
first
dose
antibiot
influenc
mortal
addit
data
provid
tabl
mortal
rate
patient
receiv
antibiot
within
h
present
emerg
depart
respect
remov
patient
receiv
antibiot
prior
present
emerg
depart
data
number
patient
h
h
h
respect
correspond
mortal
rate
one
thousand
nine
hundr
seventythre
patient
receiv
singl
antibiot
treatment
pneumonia
patient
receiv
levofloxacin
one
hundr
eightyeight
patient
receiv
cefuroxim
azithromycin
addit
patient
receiv
two
antibiot
patient
receiv
three
patient
receiv
four
patient
receiv
five
antibiot
instanc
multipl
antibiot
repres
sequenti
therapi
five
factor
significantli
associ
mortal
multivari
analysi
tabl
pneumonia
sever
ill
score
increas
age
site
care
consult
respirologist
infecti
diseas
physician
function
statu
time
admiss
use
wheelchair
bedridden
time
hospit
admiss
associ
increas
mortal
fifth
factortreat
levofloxacin
onlywa
protect
mortal
addit
complianc
pathway
margin
associ
reduct
mortal
although
signific
strong
factor
identifi
tabl
compar
die
earli
within
day
hospit
admiss
die
late
day
admiss
tabl
show
factor
associ
earli
late
mortal
multivari
analysi
increas
pneumonia
sever
risk
score
increas
age
site
hospit
function
statu
consult
infecti
diseas
physician
respirologist
independ
associ
earli
late
mortal
contrast
partial
complet
use
pneumonia
pathway
margin
associ
decreas
earli
mortal
effect
late
mortal
low
lymphocyt
count
high
potassium
level
associ
earli
late
mortal
type
antibiot
therapi
effect
late
earli
mortal
treatment
levofloxacin
alon
cefuroxim
plu
azithromycin
associ
decreas
mortal
compar
treatment
antibiot
one
patient
potassium
level
mmoll
chronic
renal
failur
receiv
dialysi
howev
other
creatinin
level
mmoll
indic
acut
renal
failur
evid
mani
factor
contribut
mortal
among
patient
requir
hospit
treatment
cap
group
patient
factor
process
care
factor
physician
factor
factor
fine
co
worker
deriv
pneumonia
sever
ill
score
base
item
includ
demograph
factor
comorbid
physic
examin
find
laboratori
radiograph
data
score
rang
point
given
patient
year
age
without
comorbid
physiolog
abnorm
higher
score
indic
sever
pneumonia
origin
studi
patient
group
five
risk
class
mortal
class
iii
point
low
risk
death
mortal
rate
class
iv
class
v
sinc
mortal
patient
risk
class
ii
studi
low
insuffici
estim
pneumonia
sever
analyz
continu
score
even
though
age
major
driver
fine
risk
score
one
point
given
year
age
male
subject
point
subtract
total
age
point
femal
subject
found
increas
age
still
contribut
risk
mortal
account
sever
score
thu
carri
addit
adjust
age
final
logist
regress
model
due
residu
confound
addit
independ
associ
age
mortal
observ
multivari
logist
regress
cox
proport
hazard
model
pneumonia
sever
score
consid
factor
might
import
mortal
name
function
statu
site
care
process
care
ethnic
also
import
factor
influenc
mortal
due
pneumonia
haa
et
al
found
hispan
asian
american
lower
risk
death
cap
white
california
one
studi
africanamerican
men
admit
veteran
affair
hospit
unit
state
lower
riskadjust
mortal
varieti
condit
includ
pneumonia
popul
alberta
white
one
hundr
thirteen
patient
aborigin
canadian
administr
databas
studi
person
admit
hospit
pneumonia
alberta
period
patient
aborigin
treati
statu
constitut
compris
studi
popul
studi
aborigin
statu
associ
increas
mortal
current
studi
mortal
rate
among
aborigin
descent
low
howev
patient
consider
younger
remaind
pneumonia
popul
like
risk
class
iii
major
find
studi
contribut
function
statu
time
hospit
admiss
independ
predictor
mortal
thu
patient
wheelchair
bedridden
time
time
respect
like
die
compar
patient
walk
without
problem
two
hundr
nineteen
person
use
wheelchair
person
bedridden
casecontrol
studi
patient
year
age
pneumonia
riquelm
et
al
report
crude
mortal
rate
bedridden
state
rel
risk
mortal
studi
patient
copd
oga
et
al
note
exercis
capac
health
statu
significantli
predict
mortal
independ
age
airflow
limit
davi
cowork
studi
person
admit
tertiari
teach
hospit
cerebrovascular
diseas
pneumonia
found
function
statu
much
predict
valu
inhospit
mortal
laboratori
data
inde
requir
total
assist
bath
best
singl
predictor
inhospit
mortal
uniqu
studi
saliv
et
al
follow
men
women
year
age
year
two
hundr
fortythre
men
women
die
pneumonia
limit
activ
daili
live
cognit
impair
independ
associ
significantli
increas
risk
pneumonia
mortal
treatment
levofloxacin
associ
major
reduct
mortal
sinc
random
clinic
trial
difficult
conclud
effect
sole
due
antibiot
pathway
encourag
levofloxacin
use
fact
patient
treat
levofloxacin
low
mortal
could
also
indic
physician
seldom
chang
therapi
patient
respond
treatment
inde
confound
indic
also
indic
protocol
care
antibiot
consist
guidelin
lead
lower
mortal
furthermor
observ
demonstr
superior
quinolon
cephalosporinmacrolid
combin
noteworthi
howev
find
administr
antibiot
therapi
h
present
emerg
depart
associ
increas
mortal
describ
other
recent
silber
et
al
also
unabl
show
associ
time
arriv
emerg
depart
antibiot
therapi
time
achiev
stabil
mortal
patient
cap
ill
typic
begin
day
patient
present
hospit
seem
unusu
delay
administr
antibiot
therapi
hour
would
associ
increas
mortal
rate
absenc
data
random
control
trial
difficult
sure
real
find
even
though
standard
care
time
administr
antibiot
therapi
appropri
import
note
studi
silber
et
al
differ
two
studi
found
increas
mortal
rate
time
arriv
emerg
depart
first
dose
antibiot
prolong
studi
dealt
medicar
patient
definit
year
age
also
noteworthi
houck
et
al
could
demonstr
effect
receiv
antibiot
therapi
prior
present
treatment
hospit
c
independ
risk
factor
increas
mortal
overal
earli
late
mortal
model
adjust
factor
hospit
factor
teach
statu
type
ownership
locat
associ
differ
mortal
varieti
condit
understaf
hospit
nurs
also
associ
increas
mortal
studi
hospit
higher
mortal
rate
one
three
hospit
edmonton
medicin
hous
staff
conjunct
hospit
part
region
health
author
one
administr
monitor
nursestaf
pattern
part
studi
greater
physician
experi
pneumonia
indic
number
patient
treat
hospit
ill
per
year
reflect
lower
mortal
rate
thu
least
two
factor
may
differ
hospit
higher
mortal
end
first
year
studi
note
higher
mortal
rate
hospit
c
review
death
pneumonia
note
one
prevent
death
requir
consult
infecti
diseas
physician
respirologist
associ
increas
mortal
rate
consult
like
deterior
specif
complic
thu
indic
complic
hospit
cours
ie
confound
indic
pneumonia
sever
score
measur
sever
time
hospit
admiss
ill
dynam
serial
measur
sever
ill
necessari
understand
subsequ
cours
ill
one
interest
find
studi
risk
factor
earli
late
mortal
differ
substanti
type
antibiot
therapi
affect
late
mortal
austrian
gold
larg
studi
bacterem
pneumococc
pneumonia
earli
note
treatment
penicillin
effect
mortal
first
day
ill
mortensen
et
al
care
determin
caus
death
patient
die
within
day
enrol
studi
cap
fiftythre
percent
death
pneumonia
relat
factor
predict
pneumoniarel
mortal
includ
hypothermia
alter
mental
state
increas
serum
urea
nitrogen
level
chronic
liver
diseas
leukopenia
hypoxemia
factor
predict
pneumoniaunrel
mortal
includ
dementia
immunosuppress
condit
activ
cancer
systol
hypotens
male
gender
multilobar
pulmonari
infiltr
increas
age
evid
aspir
predict
pneumoniarel
unrel
mortal
studi
patient
sever
ard
sever
acut
respiratori
syndrom
lymphopenia
l
lymphopenia
sever
acut
respiratori
syndrom
patient
peak
week
record
lymphocyt
count
time
hospit
admiss
studi
die
within
day
hospit
admiss
lymphopen
hospit
admiss
vs
survivor
die
day
hospit
admiss
lymphopen
vs
survivor
clearli
role
lymphocyt
pneumoniarel
mortal
requir
investig
note
hiv
statu
play
role
lymphopenia
predict
mortal
hivposit
patient
studi
none
die
hospit
lymphopenia
also
marker
malnutrit
one
studi
malnutrit
associ
higher
mortal
among
men
women
pneumonia
hyperkalemia
independ
predictor
earli
mortal
studi
studi
patient
cap
chile
die
hospit
hyperkalemia
one
factor
associ
mortal
sinc
number
patient
acut
renal
failur
like
play
role
hyperkalemia
studi
sever
strength
prospect
patient
diagnosi
cap
enrol
limit
studi
includ
fact
case
definit
allow
nonradiologist
diagnos
pneumonia
chest
radiographi
approxim
patient
chest
radiograph
read
pneumonia
radiologist
howev
interobserv
intraobserv
variabl
interpret
chest
radiograph
patient
possibl
pneumonia
radiologist
well
known
air
bronchogram
atelectasi
copd
usual
recogn
nonradiologist
patient
radiograph
read
radiologist
pneumonia
fact
pneumonia
studi
simultan
obtain
highresolut
ct
hrct
scan
chest
chest
radiograph
compar
patient
present
presum
cap
hrct
identifi
case
appar
chest
radiographi
addit
case
thu
pneumonia
studi
identifi
chest
radiographi
somewhat
similar
studi
perform
hospit
patient
addit
inform
provid
hrct
result
chang
treatment
plan
patient
conclus
shown
follow
factor
independ
associ
mortal
among
patient
cap
requir
admiss
hospit
pneumonia
sever
score
increas
age
function
statu
time
hospit
admiss
requir
consult
respirologist
infecti
diseas
physician
treatment
levofloxacin
associ
decreas
risk
mortal
also
shown
factor
associ
earli
mortal
differ
associ
late
mortal
